MRNA 📈 Moderna - Overview

Moderna, Inc. is a biotechnology company that focuses on the discovery, development, and commercialization of messenger RNA therapeutics and vaccines, addressing a wide range of diseases and conditions, including infectious diseases, immuno-oncology, rare diseases, autoimmune diseases, and cardiovascular diseases. The company's portfolio includes respiratory vaccines such as COVID-19, influenza, and respiratory syncytial virus, as well as latent vaccines like cytomegalovirus and human immunodeficiency virus vaccines. Additionally, Moderna develops public health vaccines, including those for Zika, Nipah, and Mpox, and infectious diseases vaccines like lyme and norovirus vaccines.

The company's product pipeline also encompasses systemic secreted and cell surface therapeutics, cancer vaccines, including personalized cancer, KRAS, and checkpoint vaccines, as well as intratumoral immuno-oncology products. Furthermore, Moderna is working on rare disease intracellular therapeutics and inhaled pulmonary therapeutics. To accelerate its research and development efforts, the company has established strategic alliances and collaborations with major pharmaceutical companies, such as AstraZeneca, Merck & Co., Inc, and Vertex Pharmaceuticals Incorporated, as well as research institutions and organizations like the Defense Advanced Research Projects Agency, the Biomedical Advanced Research and Development Authority, and The Bill & Melinda Gates Foundation.

Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. The company has undergone significant transformations, including a name change from Moderna Therapeutics, Inc. to Moderna, Inc. in August 2018. With a strong focus on innovation and a commitment to improving human health, Moderna has established itself as a leading player in the biotechnology industry. The company's common stock is listed on the NASDAQ stock exchange under the ticker symbol MRNA, and its web presence can be found at https://www.modernatx.com. Moderna's ISIN is US60770K1079, and it is classified under the GICS Sub Industry: Biotechnology.